Reviva Pharmaceuticals Holdings Inc. (RVPH NASDAQ) stock market data APIs
$0.8564
0.03(3.5%)
as of May 7, 2026
Try our APIs with
free plan!
Reviva Pharmaceuticals Holdings Inc. Financial Data Overview
Price chart is built with
Anychart
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, such as schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis. It also engages in the clinical development for respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis. In addition, the company is in preclinical development for the treatment of psoriasis; and RP1208 for the treatment of depression and obesity. The company was founded in 2018 and is headquartered in Cupertino, California.
Prev. Close
0.8564
Open
0.8825
High
0.8937
Low
0.8344
52 wk Range
0.59-23.2
Market Cap
11 048 K
Shares Outstanding
12 810 K
EPS
-0.5734
Beta
0.753
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Reviva Pharmaceuticals Holdings Inc. data using free add-ons & libraries
Get Reviva Pharmaceuticals Holdings Inc. Fundamental Data
Reviva Pharmaceuticals Holdings Inc. Fundamental data includes:
- Net Revenue:
- EBITDA: -10 103 922
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Reviva Pharmaceuticals Holdings Inc. Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-03-31
- EPS/Forecast: NaN
Get Reviva Pharmaceuticals Holdings Inc. End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Reviva Pharmaceuticals Holdings Inc. News
New
Does Cobenfy Have the Potential to Become a Top Drug for BMY?
Bristol Myers’ BMY schizophrenia drug Cobenfy delivered a sound performance in 2025. Cobenfy (xanomeline and trospium chloride), formerly KarXT, is an oral medication. It represents the first new p...
Analysts Remain Confident in Reviva Pharmaceuticals Holdings (RVPH) Amid 1-for-20 Reverse Stock Split
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) earns a place on our top 10 stocks under $5 that could triple.Analysts Remain Confident in Reviva Pharmaceuticals Holdings (RVPH) Amid 1-for-20 Reve...
Reviva Pharma Soars After Closing $10 Mln Public Offering, Now Expects Cash Runway Through Q1, 2027
(RTTNews) - Reviva Pharmaceuticals Holdings, Inc. (RVPH), a late-stage biopharmaceutical company, saw its shares rise by more than 6% in the pre-market after announcing the closing of its previously a...
Reviva Pharma Prices $10 Mln Public Offering Of Shares And Series G And H Warrants; Stock Down
(RTTNews) - Reviva Pharmaceuticals Holdings, Inc. (RVPH), a late-stage biopharmaceutical company, priced its previously announced public offering for the sale of 6.66 million shares, together with ser...
Get Reviva Pharmaceuticals Holdings Inc. fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
